Wearable Glucose Monitors Go Mainstream, But Experts Warn Healthy Users Lack a Framework to Act on the Data

Walk into any pharmacy in 2026 and you can pick up a continuous glucose monitor without a prescription — a small sensor that sits just under the skin and sends a running account of your blood sugar to your phone, minute by minute. A year ago, that kind of real-time metabolic data was the exclusive province of people managing diabetes. Now it's a wellness product, marketed to anyone curious about how a bowl of pasta or a morning run moves the needle on their body chemistry.

The technology itself has a long history. Glucose tracking began in the early 1970s with urine test strips, then moved to the finger-prick glucometers of the 1980s, and eventually to the under-the-skin continuous sensors developed in the early 2000s. Those early continuous monitors could take a reading every fifteen minutes; modern versions sample far more frequently. The cutting edge now includes watches and rings that use light-based sensors and machine learning to read glucose without breaking the skin at all. For decades, you needed a doctor's prescription to get one. That changed in March 2024, when the FDA cleared the first over-the-counter continuous glucose monitor for sale in the United States.

For people with diabetes, these devices are genuinely transformative. The key metric is called "time in range" — the percentage of the day a person's blood glucose stays within healthy limits — and there are well-developed clinical guidelines for how to act on that number. People with Type 1 diabetes, whose bodies don't produce enough insulin, use it to decide when to dose. People with Type 2 use it to gauge how their medications and lifestyle choices are working. The stakes are concrete and the interpretive framework is solid.

The picture gets murkier for everyone else. For a person without diabetes, blood glucose typically runs between 70 and 120 milligrams per deciliter, rising above 140 after a meal before the pancreas releases insulin and brings it back down. Exercise helps too — muscles burn glucose, so a workout can smooth out a spike. These rhythms are normal and expected. But what counts as a worrying pattern in someone who isn't diabetic? Nobody has a definitive answer yet.

That gap matters because the audience for these devices is growing fast. Researchers and physicians point out that nearly 11 million American adults with diabetes don't know they have it, according to a 2026 CDC report, and Type 2 diabetes can develop silently for years with elevated glucose as the only sign. More striking still, 115.2 million Americans — 43.5 percent of all U.S. adults — have prediabetes, a condition where the metabolic system is showing early warning signs but hasn't crossed the clinical threshold. Prediabetes is reversible, and watching how diet and exercise move your glucose number could, in theory, motivate the changes needed to pull back from the edge.

And for some people, it does. Behavioral scientists who have studied healthy users of continuous monitors report a genuine "wow factor" — people are often startled to see how sharply a sugary drink or even a banana spikes their glucose. In one study, participants described becoming more deliberate about their food choices: cutting back on late-night eating, leaving half a fast-food meal on the tray, snacking less. One participant put it plainly — seeing the numbers in real time made them more aware, and awareness led to change.

The trouble is that nobody knows how long those changes last, or whether responding to glucose fluctuations in a particular way actually reduces disease risk for someone who doesn't have diabetes. The "time in range" framework that guides diabetic care doesn't translate. There is no equivalent set of guidelines telling a healthy person what their glucose curve should look like across a day, or what an unusual pattern might mean for their future health. Without that framework, a stream of numbers is just noise — and noise, for some people, becomes anxiety.

Researchers are working to fill that void. Some teams are building mathematical models to examine what glucose does during sleep in people without diabetes, looking for early signals of metabolic disease — Type 2 diabetes, heart disease, fatty liver. Others are exploring how the same meal or workout produces different glucose responses in different people, laying the groundwork for genuinely personalized health guidance. The data is rich; the interpretive science is still catching up.

Until it does, the continuous glucose monitor sits in an odd position: a powerful tool in search of a manual. The device can tell you what your body is doing. What that means — and what, if anything, you should do about it — remains an open question.